Description: Kane Biotech Inc., a biotechnology company, researches, develops, and commercializes technologies and products that prevent and remove microbial biofilms worldwide. It develops wound care solutions under the DispersinB trademark; medical device coatings under the Aledex trademark; shampoo for dogs, cats, and horses under the Alosera trademark; and pet oral care solutions under the StrixNB and bluestem trademarks. The company was founded in 2001 and is based in Winnipeg, Canada.
Home Page: kanebiotech.com
290-100 Innovation Drive
Winnipeg,
MB
R3T 6G2
Canada
Phone:
204 453 1301
Officers
| Name | Title |
|---|---|
| Mr. Marc Edwards | Pres, CEO & Director |
| Mr. Ray Dupuis | Chief Financial Officer |
| Mr. Kevin Cole | Pres & CEO of STEM Animal Health Inc |
| Dr. Gregory S. Schultz Ph.D. | Chief Scientific Officer & Member of Scientific Advisory Board |
| Lorne Gorber | Investor Relations |
| Ms. Lori Christofalos | VP of Quality & Compliance |
| Ms. Wendy Nachtigall | Director of Marketing |
| Nicole Sendey | Investor Relations Adviser |
| Mr. Mark Ahrens-Townsend | Advisor |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 102.6115 |
| Price-to-Sales TTM: | 3.4507 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |